Systematic literature review of the burden of disease and treatment for transfusion-dependent β-thalassemia

M Betts, PA Flight, LC Paramore, L Tian… - Clinical Therapeutics, 2020 - Elsevier
Purpose β-Thalassemia is an inherited blood disorder characterized by reduced or no
production of adult hemoglobin. Systematic identification of the burden of β-thalassemia with …

[HTML][HTML] The emerging role of ferroptosis in cardiovascular diseases

M Hong, J Rong, X Tao, Y Xu - Frontiers in Pharmacology, 2022 - frontiersin.org
Ferroptosis is one type of programmed cell death discovered in recent years, which is
characterized by iron-dependent lipid peroxidation and participating in iron, lipid and …

How we manage iron overload in sickle cell patients

TD Coates, JC Wood - British journal of haematology, 2017 - Wiley Online Library
Blood transfusion plays a prominent role in the management of patients with sickle cell
disease (SCD), but causes significant iron overload. As transfusions are used to treat the …

A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA)

DJ Pennell, JB Porter, A Piga, Y Lai… - Blood, The Journal …, 2014 - ashpublications.org
Randomized comparison data on the efficacy and safety of deferasirox for myocardial iron
removal in transfusion dependent patients are lacking. CORDELIA was a prospective …

[HTML][HTML] Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity

J Sripetchwandee, N Pipatpiboon, N Chattipakorn… - PLoS …, 2014 - journals.plos.org
Background Excessive iron accumulation leads to iron toxicity in the brain; however the
underlying mechanism is unclear. We investigated the effects of iron overload induced by …

[HTML][HTML] Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta …

GJH Snel, M van den Boomen, LM Hernandez… - Journal of …, 2020 - Elsevier
Background The clinical application of cardiovascular magnetic resonance (CMR) T 2 and T
2* mapping is currently limited as ranges for healthy and cardiac diseases are poorly …

[HTML][HTML] Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox

NF Olivieri, A Sabouhanian, BL Gallie - PLoS One, 2019 - journals.plos.org
Background Iron overload, resulting from blood transfusions in patients with chronic
anemias, has historically been controlled with regular deferoxamine, but its parenteral …

[HTML][HTML] Relationship between serum ferritin and outcomes in β-thalassemia: a systematic literature review

F Shah, K Huey, S Deshpande, M Turner… - Journal of Clinical …, 2022 - mdpi.com
Among the difficulties of living with β-thalassemia, patients frequently require blood
transfusions and experience iron overload. As serum ferritin (SF) provides an indication of …

Cross-talk between available guidelines for the management of patients with beta-thalassemia major

KM Musallam, M Angastiniotis, A Eleftheriou… - Acta …, 2013 - karger.com
Efforts to optimize the management of patients with β-thalassemia major (TM) continue to
expand. Evidence from biomedical research evaluating safe and careful processing …

[HTML][HTML] Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer

T Lu, J Tang, B Shrestha, BR Heath, L Hong, YL Lei… - Theranostics, 2020 - ncbi.nlm.nih.gov
Ovarian cancer (OC) is estimated to kill~ 14,000 women in the United States in 2019.
Current chemotherapies to treat OC initially show therapeutic efficacy but frequently drug …